⏳ The November Cliff Meets Courtroom Reality, Plus Governors Coordinate On Hemp

Built by a former cannabis regulator, Policy, Decoded helps operators read the policy terrain before it shifts beneath their feet.

Today’s edition starts with the November federal hemp deadline and an underpriced consequence: once a business falls into ongoing federal illegality, bankruptcy relief often goes from tool to mirage. Our Decoded Insight also flags something we are proud of: a commentary we authored in Clinical Therapeutics on medical cannabis safety, clinical risk, and the standards gap that still leaves patients doing too much of the risk management themselves. We also track governors quietly coordinating across state lines, South Carolina’s two-bill showdown on hemp THC, and Rhode Island’s tightening posture on hemp drinks alongside adult-use licensing litigation.

Policy, Decoded is written daily by THC Group, where we advise operators, investors, trade groups, and governments on policy, regulatory, and political headaches that do not come with clean rulebooks. Today’s sponsor is The Flyover.

⏳ Paperwork Has A Long Memory
🥤 Hemp Drinks Get The Tightening Grip
🏛️ Coordination Beats Chaos

Keep it in writing.

📌 What Happened: A new legal analysis highlights a secondary consequence of the federal hemp deadline that has received little attention outside restructuring circles. Once a business is operating in ongoing violation of federal law, bankruptcy courts have routinely refused to provide relief, even when the company was previously compliant. For hemp operators, that matters because compliance status can change overnight if products exceed the federal THC threshold or if licensing lapses. Courts have historically drawn a hard line around supervising enterprises tied to federally unlawful activity, regardless of state legality or prior good faith operations.

💡 Why It Matters: Bankruptcy is not just a last resort. It is the backbone of how creditors price risk, how lenders structure covenants, and how distressed businesses preserve value in an orderly way. When bankruptcy is effectively unavailable, leverage shifts quickly. Creditors move earlier. Terms tighten. Mistakes become harder to unwind. For hemp operators, the risk is not theoretical. A single failed test, a missed regulatory deadline, or an unresolved compliance question can flip a company’s posture from federally lawful to federally exposed, with downstream consequences for restructuring options.

⚖️ NRA And NORML Team Up Against Federal Gun Ban For Marijuana Users

The NRA and NORML filed on the same side in a Supreme Court case challenging the federal ban on firearm possession by unlawful controlled substance users, a prohibition sweeping in state-legal cannabis consumers. Oral argument is set for March 2nd, with the government seeking to revive prosecution of a marijuana user under federal firearms statutes. Briefs across ideological lines argue the law lacks workable historical analog under current Second Amendment doctrine and invites arbitrary enforcement given fuzzy lines on use timing and frequency. The collision is practical. Millions live in legal or tolerated cannabis markets while federal forms and criminal liability assume hard prohibition. Pressure builds for either narrower impairment-based standards or clearer federal rules that stop categorically converting ordinary consumers into felons. (Reason)

🏛️ Governors Quietly Start Comparing Notes On Cannabis And Hemp

The National Governors Association convened a multi-state roundtable pulling in 11 states and industry stakeholders to discuss cannabis and hemp policy. Sessions covered cannabinoid market dynamics, public health strategies, sustainable marketplace development, and state influence on federal reform. The real work is coordination. States are watching identical product categories, enforcement gaps, and consumer safety questions collide across their borders. When governors staff up around shared frameworks, policy converges faster and bad actors exploiting state-to-state seams lose room to operate. (National Governors Association)

🤠 Texas Lawmakers Pivot Toward Regulating Hemp THC

A bipartisan group of Texas lawmakers is advancing a regulatory framework for hemp THC products next session. Their argument: the market has outgrown any fantasy that prohibition will work. The pitch reflects a shift inside the capitol after last year's intraparty collision, when prohibition proposals met consumer demand, retail sprawl, and enforcement realities on the ground. The policy lane takes shape: licensing, testing, labeling, age gates, retail rules drawing clear lines between compliant products and synthetic chaos. The framing boxes in the politics. Texas can build a controlled lane that survives legal challenge or continue cycling through headline bans that change nothing by morning. The fight narrows to rule-writing and market access, with rising risk for anyone betting on sustained ambiguity. (Marijuana Moment)

🧨 South Carolina’s Hemp Drink Fight Turns Into A Two-Bill Showdown

South Carolina lawmakers are preparing a direct choice this week between two competing approaches to hemp THC: outright ban versus regulated lane. House debate centers on psychoactive hemp products legislators say are reaching kids too easily, with last year's action already pushing the purchase age to 21. The regulation concept narrows the category to a controlled channel by limiting hemp beverages to liquor stores, capping each can at 12 ounces and 5 milligrams of delta-9 THC. Supporters pitch a consumer safety framework that keeps compliant businesses alive while giving law enforcement workable tools. The political subtext is familiar: ban bills grab headlines, regulatory bills survive, and whichever version moves first shapes what the Senate carries the rest of the session. (WRDW/WAGT)

🥤 Rhode Island Cannabis Regulators Float New Hemp Drink Restrictions

Rhode Island regulators are moving toward a tighter, more cannabis-like framework for hemp-derived THC beverages, with draft recommendations due to the General Assembly by March 1st. The flashpoint is a proposed ban on on-premise service at restaurants and bars, which drew immediate pushback from hospitality and liquor stakeholders who argued those settings are where controls and monitoring work best. The draft package also leans into stronger testing expectations, including Department of Health certification for out-of-state labs and a push toward cannabis-equivalent panels for contaminants and potency. Taxes remain a live wire, with the commission floating either a cannabis-style add-on or a higher wholesale-based approach, both of which industry warned could land out of step with neighboring states. The quieter tell is timing, since federal potency limits scheduled for November are already shaping state planning and regional coordination, whether the politics want to admit it or not. (Rhode Island Current)

⚖️ Rhode Island Officials Fight Bid To Freeze Adult Use Licensing

Rhode Island regulators are back in court trying to keep the state's adult-use retail licensing process on track as challengers seek to block or pause the program. The pressure point sits in the licensing architecture itself, including how Rhode Island structured its limited retail licenses across geographic zones and set-asides tied to social equity and worker cooperative pathways. A related constitutional fight over licensing requirements has already climbed into federal appellate posture, which keeps timing risk alive even when the state says implementation is moving forward. Every month of litigation uncertainty reshapes who can raise money, sign leases, and hire confidently, while advantaging anyone already operating in adjacent lanes. The outcome will decide not just who gets a license but whether Rhode Island's rollout looks like a controlled process or a courtroom-managed one. (Law360)

🌪️ Oklahoma Governor Calls To Repeal Medical Marijuana

Oklahoma Governor Kevin Stitt used his State of the State to call for sending medical marijuana back to a vote and shutting it down. He argued the 2018 initiative opened the door to an out-of-control industry, pointing to dispensary count and tying the market to cartel activity and other criminal concerns. The move reads less like policy adjustment and more like an attempt to reset legitimacy of the entire program. The mechanics are unclear. Stitt offered no specific ballot language, and recent initiative rule changes have already made citizen measures harder to run. A new layer of political risk settles over operators and lenders in a state where compliance has been shaped by enforcement pressure and program tightening. (Marijuana Moment)

🗳️ Florida Legalization Campaign Misses Ballot Threshold

Florida officials say Smart and Safe Florida did not submit enough validated signatures for the November 2026 ballot. Division of Elections tallied 783,592 valid signatures against an 880,062 requirement, though the campaign claims more petitions remain in processing after submitting over 1.4 million. The signature fight has run alongside lawsuits over invalidations and escalating DeSantis administration enforcement against petition activity. Adult use returns to procedural trench warfare. Donors and operators are recalculating whether Florida runs through courts and signature mechanics again or whether legislative paths become less theoretical. (Marijuana Moment)

🧀 Wisconsin Democrats Roll Out New Legalization Bill

Wisconsin Democratic lawmakers unveiled a new adult-use legalization bill framed around freedom, expungement, and regulated sales. The proposal lands in familiar territory: Republicans hold leverage, the governor continues using legalization for budget and ballot messaging. Sponsors invoke public opinion and neighboring state pressure. Wisconsin exports consumers and tax dollars while keeping enforcement and product safety in shadow. The bill functions as 2026 messaging infrastructure, giving candidates a binary question to run on. Another cycle where policy logic strengthens and legislative math remains stubborn. Gray market incentives stay in place. (Marijuana Moment)

🩺 Idaho Medical Cannabis Campaign Nears Signature Threshold

An Idaho medical marijuana campaign reports collecting more than 45,000 signatures toward a November 2026 ballot measure. The target remains steep: 70,725 valid signatures statewide, plus district spread requirements forcing genuine field work across the state. The campaign pairs signature updates with polling showing broad support, including strong Republican numbers. That changes how lawmakers calculate political risk. A separate constitutional amendment headed to voters would reserve legalization power to the legislature, creating a procedural fight over authority and timing. Spring becomes high-stakes territory where petition mechanics and constitutional framing collide in one of the last full prohibition states. (Marijuana Moment)

🏛️ Nebraska’s Cannabis Commission Hits A Governance Speed Bump

Nebraska's Medical Cannabis Commission lost its chair, Dr. Monica Oldenburg, and the body also failed to appear at a legislative hearing on a bill adjusting the voter-approved program. Lawmakers pressed for timelines and implementation mechanics without the agency supposed to answer them. The combination lands as a credibility problem in the early innings, when the state needs boring competence and predictable forward motion. It also widens the gap between voter mandate and administrative follow-through, which invites legislators to tighten the reins through statute. Rulemaking gets slower, more political, and easier to distrust before licensing even starts. (Nebraska TV)

🏝️ Hawaii Presses For A Clean Line Between Gray Market And Governance

A Hawaii Business Magazine editor argues the state has reached the end of its wink-and-nod era on cannabis. The market is culturally tolerated and commercially real while operating outside durable oversight. State taxation estimates peg the cannabis economy at roughly $240 million annually, with only a sliver running through legal channels. The public health case rests on basic consumer protections: testing, labeling, age limits. The policy case ties to revenue currently sitting underground. Hawaii carries medical legality, widespread use, and limited enforcement clarity simultaneously. Pressure is mounting for a coherent adult-use framework that pulls demand into regulated lanes and gives agencies functional tools. (Hawaii Business Magazine)

⚖️ Minnesota Appeals Court Limits State Marijuana Prosecutions In Indian Country

A Minnesota Court of Appeals panel dismissed felony marijuana possession charges against Todd Jeremy Thompson, a White Earth Band member whose reservation-based tobacco shop was raided after Minnesota legalized cannabis. The court held that once Minnesota shifted cannabis possession into a regulatory lane, this kind of on-reservation conduct by an enrolled member became a civil matter, which triggers Public Law 280's criminal versus civil jurisdictional split. The opinion leaned on language in Minnesota's 2023 law recognizing Tribal governments' sovereign right to regulate cannabis within their jurisdiction. A concurring judge went further, flagging risk that other tribes will face the same arrest pattern unless the rule applies broadly across all Minnesota PL 280 reservations. Task forces and county prosecutors now face higher litigation risk when they push state cannabis enforcement into reservation jurisdiction where state authority is thin. (Minnesota Reformer)

🥤 Dry January Turns THC Beverages Into A Habit

Dry January delivered visible THC drink sales increases, with retailers and brands treating the month as trial ground for consumers seeking social alternatives to alcohol. The bigger story unfolds after January. Repeat buyers sustain categories when products earn weekly routine status. Beverages succeed on predictability: consistent dosing, manageable onset. Low-dose formats continue capturing mainstream shelf space for this reason. Success raises regulatory stakes around age gates, labeling, testing. Success attracts corner-cutting copycats. The category continues building past calendar gimmicks, while regulators decide whether it matures inside responsible channels or gets pulled back into loophole warfare. (MJBizDaily)

🔬 Terpene Belt Farms Joins UCLA-Led Cannabis Research Grant

Nexus AgriScience's subsidiary Terpene Belt Farms was selected as industry partner on a California Department of Cannabis Control research grant led by UCLA. The project aims to characterize naturally occurring flavor and aroma compounds in cannabis flower and establish concentration benchmarks regulators can use. This lands in the middle of a live enforcement problem. California limits non-cannabis additives in inhalable products yet lacks authoritative reference data for what qualifies as naturally occurring. A reliable dataset becomes practical infrastructure for rulemaking, testing protocols, and enforcement decisions currently relying on judgment over evidence. The result: clearer boundaries between legitimate chemistry and engineered additives, with less room for operators hiding behind ambiguity. (Cannabis Business Times)

🧪 Vape Sellers Challenge Texas Ban On China-Sourced Vape Liquid

Vape distributors and retailers are suing Texas to block enforcement of a law prohibiting sale of e-cigarettes using consumable vape liquid manufactured in China. Plaintiffs argue the restriction is unconstitutional and seek to halt state enforcement while the case proceeds. The dispute sits at the intersection of youth-focused political pressure, supply chain reality, and a market where much current inventory runs through overseas inputs. If the law stands, retailers and brands face rapid sourcing changes, write-downs, and product redesign favoring a smaller set of compliant supply chains. Immediate commercial triage for shops and wholesalers, plus higher risk premium for any category built on cross-border ingredients. (Law360)

🌱 Scotts Holds Guidance As Cannabis Exit Moves Closer

Scotts Miracle-Gro reported a wider first quarter loss in its slow season while maintaining its full-year outlook. Management attributes the stance to cost control and expectations that core lawn and garden cycles carry the year despite choppy near-term results. The consequential detail sits below the earnings table: Scotts is advancing its plan to exit cannabis supply exposure by divesting Hawthorne Gardening. As the Vireo Growth deal progresses, Scotts signals investors should evaluate 2026 on cleaner operations, not volatility hangover. (MSN)

🧾 Context: Medical cannabis now sits inside real treatment plans for nausea, pain, sleep, spasticity, and seizure disorders. U.S. oversight still runs through a state-by-state patchwork with inconsistent thresholds, uneven testing panels, and enforcement that often arrives after exposure. Microbial contamination persists inside regulated markets, and pathogenic Aspergillus has been detected in products that cleared culture-based screens. Chemical contaminants add cumulative risk and can plausibly shape drug metabolism in patient populations already living on tight therapeutic margins. Sampling remains the quiet structural weakness, because many states still let the regulated business choose the sample that defines the batch.

🔎 What It Signals: The market has outgrown standards built for agriculture and borrowed from food models, especially for inhaled products used by immunocompromised patients. Culture-based yeast and mold screens can create a false sense of safety when the clinical risk turns on pathogen-specific detection that better matches bedside reality. State reforms that reduce obvious lab shopping help, and they still leave incentives in place that can bend outcomes when sampling integrity is weak. International models show a more mature posture, with pharmacopoeial standards, validated methods, and distribution systems that treat medical cannabis like a medical product. Equity keeps showing up as a safety constraint, because patients priced out of regulated channels get pushed toward cheaper products with fewer safeguards.